Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRASH-4 intramuscular tranexamic acid in older adults with mild traumatic brain injury
2020-003391-40Phase 3Unknown
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in traumatic brain injury (TBI) comparing Intramuscular tranexamic acid with Placebo (2 arms). Primary endpoint: Discharge from the emergency department within 24 hours of arrival. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2020-003391-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-003391-40.